|Articles|January 29, 2021
Determine Nitrosamines in Active Pharmaceutical Ingredients
Author(s)Agilent Technologies, Inc.
This application note describes the highly sensitive analysis of nitrosamine impurities in active pharmaceutical ingredients to quantify genotoxic impurities.
Related Content
Trending on LCGC International
1
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
2
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
3
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
4
Industry Roundup: Thermo Fisher Scales Orbitrap Platform Across Research, Biopharma, and Environmental Testing at ASMS 2026
5